{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Weekly+Assessment&page=65", "query": { "intervention": "Weekly Assessment", "page": 65 }, "page_size": 10 }, "pagination": { "page": 65, "page_size": 10, "total_count": 6232, "total_pages": 624, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Weekly+Assessment&page=66&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Weekly+Assessment&page=64&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T06:27:16.085Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05113342", "title": "Descartes-25 in Relapsed/Refractory Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma", "Relapse Multiple Myeloma" ], "interventions": [ { "name": "Descartes-25", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cartesian Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2021-11-25", "completion_date": "2024-11-08", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 2, "location_summary": "Shreveport, Louisiana • Bethesda, Maryland", "locations": [ { "city": "Shreveport", "state": "Louisiana" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05113342" }, { "nct_id": "NCT03759366", "title": "A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myasthenia Gravis", "Myasthenia Gravis, Juvenile Form", "Myasthenia Gravis, Generalized" ], "interventions": [ { "name": "Eculizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12, "start_date": "2018-12-28", "completion_date": "2023-11-06", "has_results": true, "last_update_posted_date": "2024-12-11", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 8, "location_summary": "Los Angeles, California • Tampa, Florida • Chicago, Illinois + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03759366" }, { "nct_id": "NCT05400122", "title": "Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Cancer", "Hematologic Malignancy", "Rectum Cancer", "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Acute Lymphoblastic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Hodgkin Lymphoma", "Non Hodgkin Lymphoma", "Myeloproliferative Syndrome", "Plasma Cell Myeloma", "Gastric Cancer", "Esophageal Cancer", "Esophagus Cancer", "Gastric Cancer, Metastatic", "Unresectable Esophageal Cancer", "Metastatic Esophageal Cancer" ], "interventions": [ { "name": "Vactosertib", "type": "DRUG" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "IL-2", "type": "DRUG" }, { "name": "Natural Killer Cells", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Wald", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2022-09-09", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05400122" }, { "nct_id": "NCT02992405", "title": "FOCUS:Families OverComing Under Stress", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer", "Depression", "PostTraumatic Stress Disorder", "Anxiety" ], "interventions": [ { "name": "FOCUS Resilience Enhancement Program", "type": "BEHAVIORAL" }, { "name": "Waitlist (No Study Treatment)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 32, "start_date": "2016-12-05", "completion_date": "2018-05-18", "has_results": false, "last_update_posted_date": "2019-02-07", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02992405" }, { "nct_id": "NCT02410356", "title": "Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Growth Hormone Deficiency" ], "interventions": [ { "name": "TV-1106", "type": "DRUG" }, { "name": "dGH", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2015-04-30", "completion_date": "2016-04-30", "has_results": false, "last_update_posted_date": "2021-12-10", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 32, "location_summary": "Artesia, California • Fountain Valley, California • Lakewood, California + 22 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Lakewood", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT02410356" }, { "nct_id": "NCT01112722", "title": "Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Osteoarthritis of the Knee" ], "interventions": [ { "name": "Apitox, purified honeybee toxin, lyophilized in saline", "type": "BIOLOGICAL" }, { "name": "histamine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Apimeds, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 363, "start_date": "2013-12", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2016-12-13", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 15, "location_summary": "Gulf Shores, Alabama • Tucson, Arizona • Garden Grove, California + 11 more", "locations": [ { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Thousand Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01112722" }, { "nct_id": "NCT00723853", "title": "REACH-OUT: Chicago Children's Diabetes Prevention Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Type 2 Diabetes" ], "interventions": [ { "name": "Reach-Out Program, nutritional and exercise program", "type": "BEHAVIORAL" }, { "name": "Reach-In Program, standard of care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "9 Years to 65 Years" }, "enrollment_count": 131, "start_date": "2008-04", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2013-09-05", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00723853" }, { "nct_id": "NCT01219777", "title": "Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \\Bevacizumab for Primary Ovarian", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Cancer", "Primary Peritoneal Cancer", "Fallopian Tube Cancer" ], "interventions": [ { "name": "carboplatin", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ritu Salani", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "FEMALE", "summary": "18 Years to 90 Years · Female only" }, "enrollment_count": 9, "start_date": "2010-09", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2018-02-08", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01219777" }, { "nct_id": "NCT03865875", "title": "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "Exercise Program", "type": "BEHAVIORAL" }, { "name": "Nutrition Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-08-13", "completion_date": "2024-08", "has_results": false, "last_update_posted_date": "2021-05-17", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03865875" }, { "nct_id": "NCT00713505", "title": "Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Survivor", "Cognitive/Functional Effects", "Leukemia", "Long-term Effects Secondary to Cancer Therapy in Children", "Lymphoma", "Psychosocial Effects of Cancer and Its Treatment" ], "interventions": [ { "name": "educational intervention", "type": "OTHER" }, { "name": "psychosocial assessment and care", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "6 Years to 16 Years" }, "enrollment_count": 56, "start_date": "2008-05", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2010-10-13", "last_synced_at": "2026-11-05T06:27:16.085Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00713505" } ] }